NIH – Analysis, Technology, Leadership, Administration and Science (ATLAS) Center (U24 Clinical Trial Not Allowed)

Purpose: This Funding Opportunity Announcement intends to support the creation of an Analysis, Technology, Leadership, Administration and Science (ATLAS) Center that has the overarching goal of building the "go-to" open-access resource for the research community…

NIH – HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional)

Purpose: This funding opportunity announcement is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. The NIH…

Bill and Melinda Gates Foundation – Grand Challenges

Purpose: The Bill & Melinda Gates Foundation has launched four requests for proposals – all now open for applications – through the Grand Challenges Global Call-to-Action, inaugurating this new member…

NIH – Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 – Clinical Trial Optional)

Purpose: This funding opportunity announcement (FOA) is part of the NINDS Ultra-Rare Gene-based Therapy (URGenT) network. The mission of URGenT is to support and facilitate the development of gene-based or transcript-directed therapeutic…

NIH – Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 – Clinical Trial Optional)

Purpose: This funding opportunity announcement (FOA) encourages research relevant to the development of innovative new screening approaches and therapeutic interventions for potentially fatal or disabling conditions that have been identified…

NIH – RePORT

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for a Regional Prospective Observational Research in Tuberculosis (RePORT) International Coordinating Center (RICC) for the national RePORT…

Medical Technology Enterprise Consortium (MTEC)

Purpose: The Medical Technology Enterprise Consortium (MTEC) is excited to post this pre-announcement for a Request for Project Proposals (RPP) focused on the development and validation of an enhanced training…

Melanoma Research Alliance

Purpose: MRA anticipates supporting at least $12.8 million in new funding. Proposals are still being accepted for Young Investigator and Pilot Awards. Special Opportunities are also available in immunotherapy and…

NIH – Coordinating Center for HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network (U24 Clinical Trial Required)

Purpose: Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) solicits applications from institutions/organizations to participate as the Coordinating Center for the HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials…

NIH – Cellular Senescence Network: Murine Tissue Mapping Centers (U54 – Clinical Trial Not Allowed)

Purpose: he purpose of this Funding Opportunity Announcement (FOA) is to establish state-of-the-art Tissue Mapping Centers (TMCs) within the Cellular Senescence Network (SenNet) to build an atlas of cellular senescence…